GCDFP15 Recombinant Antibody, RBITC Conjugated
Product Specifications
Background
Gross cystic disease is a common premenopausal disorder in which gross cysts are the predominant pathologic lesion. It is characterized by production of a fluid secretion which accumulates in the breast cysts. Gross cystic disease fluid is a pathologic secretion from breast composed of several glycoproteins, including a unique 15 kDa monomer protein, GCDFP 15. The cells within the body that produce GCDFP 15 appear to be restricted primarily to those with apocrine function. Studies have found GCDFP 15 to be a highly specific and sensitive marker for breast cancer.
Synonyms
BRST-2 antibody, BRST2 antibody, GCDFP-15 antibody, GCDGP15 antibody, gp17 antibody, GPIP4 antibody, Gross cystic disease fluid protein 15 antibody, PIP antibody, PIP_HUMAN antibody, Prolactin induced protein antibody, Prolactin inducible protein precursor antibody, Prolactin-induced protein antibody, Prolactin-inducible protein antibody, SABP antibody, Secretory actin binding protein antibody, Secretory actin-binding protein antibody
Gene ID
5304
Swiss Prot
P12273
Cellular Locus
Secreted
Host
Rabbit
Cross Reactivity
Human
Target
GCDFP15
Clonality
Recombinant
Isotype
IgG
Conjugation
RBITC
Source
Synthetic Peptide within N-terminal human GCDFP 15.
Applications
WB, IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
5304
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
